Can blocking a key inflammation switch save COVID-19 patients on ventilators?
Disease control
Stopped early
Researchers test whether an experimental antibody called EB05 can reduce deaths in adults hospitalized with severe COVID-19 who need mechanical ventilation. EB05 targets a protein on immune cells that drives runaway inflammation, a major cause of acute respiratory distress syndro…
Phase 2/3 • Sponsor: Edesa Biotech Inc. • Aim: Disease control
Last updated Oct 02, 2026 00:00 UTC